1. Armah B.I. (1988): Unique presynaptic α2-receptor selectivity and specificity of the antihypertensive agent moxonidine. Arzneimittelforsch., 38, 1435–1442.
2. Emsberger P., Giuliano R., Willette R.N., Reis D.J. (1990): Role of imidazole receptors in the vasodepressor response to Clonidine analogues in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther., 253, 408–418.
3. Bricca G., Dontenwill M., Molines A., Feldman J., Belcourt A., Bousquet P. (1988): Evidence for existence of a homogenous population of imidazoline receptors in the human brainstem. Eur. J. Pharmacol., 150, 401–402.
4. Emsberger P. (1990): Moxonidine, a second-generation centrally-acting antihypertensive, binds selectively to imidazole sites in the ventrolateral medulla (VLM) and kidney. Pharmacologist, 32, 191.
5. Segler G., Gmeinhardt A. (1988): ZNS-Effekte von Moxonidine einem zentralnervös wirkenden Antihypertensivum, im Vergleich zu Clonidin und Placebo. Klin. Wochenschr., 66 (Suppl XIII), 41–42.